Autoimmunity associated with cytokine administration in cancer in humans
Cytokine administered . | Cancer targeted . | Autoimmune events . | Reference(s) . |
---|---|---|---|
IFN-α | Chronic myeloid leukemia | Thyroditis, sarcoidosis, systemic lupus erythematosus associated with autoantibodies, autoimmune thrombocytopenic purpura, acute pancreatitis, hyperthyroidism, aggravation of psoriasis | 51,107,,–110 |
IFN-α | Cutaneous T-cell lymphoma | Psoriasis | 111 |
IFN-α | Mid-gut carcinoid tumors | Systemic lupus erythematosus, pernicious anemia, thyroid disease | 112 |
IFN-α2b | Melanoma | Hypothyroidism | 113 |
IFN-α2b and piroxicam | Melanoma | Vitiligo, pulmonary interstitial fibrosis | 114 |
GM-CSF with gp100 and tyrosinase peptides | Melanoma | Vitiligo | 115 |
IL-2 | RCC | Hypothyroidism, myasthenia gravis, diabetes mellitus (insulin-dependent), and myositis | 62,–64,116 |
IL-2 | Melanoma | Vitiligo | 67 |
IL-2 | Colorectal cancer | Diabetes mellitus | 117 |
IL-2 and IFN-γ | RCC | Autoantibodies against erythrocytes | 65 |
IL-2 and IFN-α2b | RCC, melanoma | Antithyroid antibodies, hypothyroidism, autoimmune thyroiditis | 63,118,119 |
Cytokine administered . | Cancer targeted . | Autoimmune events . | Reference(s) . |
---|---|---|---|
IFN-α | Chronic myeloid leukemia | Thyroditis, sarcoidosis, systemic lupus erythematosus associated with autoantibodies, autoimmune thrombocytopenic purpura, acute pancreatitis, hyperthyroidism, aggravation of psoriasis | 51,107,,–110 |
IFN-α | Cutaneous T-cell lymphoma | Psoriasis | 111 |
IFN-α | Mid-gut carcinoid tumors | Systemic lupus erythematosus, pernicious anemia, thyroid disease | 112 |
IFN-α2b | Melanoma | Hypothyroidism | 113 |
IFN-α2b and piroxicam | Melanoma | Vitiligo, pulmonary interstitial fibrosis | 114 |
GM-CSF with gp100 and tyrosinase peptides | Melanoma | Vitiligo | 115 |
IL-2 | RCC | Hypothyroidism, myasthenia gravis, diabetes mellitus (insulin-dependent), and myositis | 62,–64,116 |
IL-2 | Melanoma | Vitiligo | 67 |
IL-2 | Colorectal cancer | Diabetes mellitus | 117 |
IL-2 and IFN-γ | RCC | Autoantibodies against erythrocytes | 65 |
IL-2 and IFN-α2b | RCC, melanoma | Antithyroid antibodies, hypothyroidism, autoimmune thyroiditis | 63,118,119 |
GM-CSF indicates granulocyte-macrophage colony-stimulating factor; and IL-2, interleukin-2.